Chorioamnionitis: implications for the neonate
- PMID: 25678002
- PMCID: PMC4331454
- DOI: 10.1016/j.clp.2014.10.011
Chorioamnionitis: implications for the neonate
Abstract
Chorioamnionitis (CA) is characterized by inflammation of the fetal membranes. The incidence increases with decreasing gestational age at birth. When suspected on clinical criteria, pathologic assessment of the placenta should be performed. Although the mechanisms are not entirely clear, CA predisposes to premature birth, neonatal sepsis, and intraventricular hemorrhage. Its role in respiratory distress syndrome, bronchopulmonary dysplasia, and neurodevelopmental impairment is mixed. Prevention and treatment are ill-defined; antibiotics for preterm premature rupture of membranes reduce the incidence and increase the length of time to delivery. Antibiotics are recommended for infants exposed to CA while laboratory studies are being performed.
Keywords: Fetal inflammatory response; Mycoplasma; Neonatal sepsis.
Copyright © 2015 Elsevier Inc. All rights reserved.
References
-
- Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. The New England journal of medicine. 1988 Oct 13;319(15):972–978. - PubMed
-
- Plakkal N, Soraisham AS, Trevenen C, Freiheit EA, Sauve R. Histological chorioamnionitis and bronchopulmonary dysplasia: a retrospective cohort study. Journal of perinatology : official journal of the California Perinatal Association. 2013 Jun;33(6):441–445. - PubMed
-
- Liu Z, Tang Z, Li J, Yang Y. Effects of placental inflammation on neonatal outcome in preterm infants. Pediatr Neonatol. 2014 Feb;55(1):35–40. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
